Abstract
22P - ESR1 mutations are similarly prevalent in newly metastatic and loco-regional recurrence of endocrine-treated breast cancer patients and carry worse prognosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have